Research

The Department of Pathology and Laboratory Medicine at Weill Cornell Medicine is both a clinical and basic science department, providing an optimal perspective for true translational research that bridges patient care with biomedical research. Our department engages in cutting-edge research with the goal of improving patient care.

The department has developed an important infrastructure to help support research, including numerous core facilities and the Center for Translational Pathology to facilitate the pipeline from discovery to implementation. Our research encompasses genomics, cell biology, and vascular biology, among other critical fields of pathology and laboratory medicine. Our faculty members take pride in performing world-class research and providing training opportunities at the graduate and post-graduate levels.

Our mission is to conduct game-changing research and to help develop the research leaders of the future.

The Division of Cell and Cancer Pathobiology, led by Dr. Jorge Moscat, is constituted by research laboratories whose overarching goals are to unravel the molecular and cellular basis of human diseases. Being part of the Department of Pathology and Laboratory Medicine offers the unique opportunity to access human specimens to validate the molecular mechanisms identified in cell and mouse models of cancer and other pathologies. In that respect, our research laboratories are uniquely positioned to develop high-impact projects with clear translational potential. The ongoing studies in our research teams range from pan-cancer genomics and RNA biology to studies in pathophysiologically relevant mouse models of cancer and the study of stem cells and bone physiology. Investigators in our Division are also leaders in cancer clinical trials, which reflects the impactful nature of our work. In summary, our faculty take pride in performing world-class research and providing outstanding training opportunities for graduates and post-graduates in laboratories poised to conduct paradigm-changing discoveries to impact the diagnosis and treatment of human diseases.

The Division of Computational Pathology, led by Dr. Luigi Marchionni, encompasses scientific objectives of digital pathology and image analysis, clinical genomics and other omics, and the integration of multi-modality data with clinical information.

We also offer a wide array of Postdoctoral research positions.

Research Labs

Covid-19 Research

The Pathology and Laboratory Medicine Department conducted cutting-edge research on COVID-19 from the earliest days of the global pandemic. In addition to using this information to care for our patients, dozens of peer-reviewed publications have advanced our understanding of the virus and improved care for patients around the world.

Newly Awarded Grants

The Department has many newly awarded grants that support our cutting-edge research benefiting patients. These grants come from private donors, governmental agencies like the National Institutes of Health, the U.S. Department of Defense, partner organizations like the Daedalus Fund for Innovation, the Lymphoma Research Foundation, and from within Cornell University and Weill Cornell Medicine.

Publications

The Pathology and Laboratory Medicine Department conducts cutting-edge research on a very wide range of human diseases and conditions. Our researchers publish hundreds of peer-reviewed scientific journal articles every year in leading publications.